X4 PHARMACEUTICALS

x4-pharmaceuticals-logo

X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment. The company is developing two unique programs such as drug candidate, X4P-001, has clinical experience in over 70 subjects, and is advancing into Phase 1/2 trials in refractory clear cell renal cell carcinoma (ccRCC) and refractory epithelial ovarian cancer (EOC), the second program, X4P-002, is a unique series of late lead molecules that penetrate the blood-brain barrier. They will pursue early clinical development in glioblastoma multiforme (GBM), a rare form of lethal brain cancer, for the X4P-002 program.

#SimilarOrganizations #People #Financial #Website #More

X4 PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical Therapeutics

Founded:
2014-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.x4pharma.com

Total Employee:
51+

Status:
Active

Contact:
+1 857 529 8300

Email Addresses:
[email protected]

Total Funding:
174.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.

redpin-therapeutics-logo

Redpin Therapeutics

Redpin Therapeutics is a preclinical stage gene therapy company that develops chemogenetics platform designed for nervous system diseases.

aravive-biologics-logo

Aravive Biologics

Aravive Biologics is a clinical stage biotechnology company focused on developing new therapies that target important survival pathways.

regenerative-bio-logo

Regenerative Bio

Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing.

rhoshan-pharmaceuticals-logo

Rhoshan Pharmaceuticals

Rhoshan Pharmaceuticals is an early-stage life sciences company focused on developing injectable presentations of commonly used oral drugs.

reven-pharmaceuticals-logo

Reven Pharmaceuticals

Reven Pharmaceuticals is a clinical-stage company providing solutions for the treatment of vascular and metabolic-related conditions.

rubius-therapeutics-logo

Rubius Therapeutics

Rubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.

nautilus-biotechnology-logo

Nautilus Biotechnology

Nautilus Biotechnology offers a high-throughput, low-cost platform for analyzing and quantifying the human proteome.

nq-medical-logo

nQ Medical

nQ Medical is a neurotechnology company allowing Data Defined Disease Management via digital biomarkers using AI.

nrx-pharmaceuticals-logo

NRx Pharmaceuticals

NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.

northsea-therapeutics-logo

NorthSea Therapeutics

NorthSea Therapeutics is a clinical-stage biotech company developing first-in class, oral, structurally-engineered lipid therapeutics.

novabay-pharmaceuticals-logo

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.

nuvox-pharma-logo

NuvOx Pharma

NuvOx Pharma is developing a nanotechnology for oxygen delivery, DDFPe, which is a best-in-class drug that is Phase II ready in stroke.

maxona-pharmaceuticals-logo

Maxona Pharmaceuticals

Maxona is a pharmaceutical company that develops and commercializes a portfolio of novel therapeutics for the treatment of pain.

milestone-pharmaceuticals-logo

Milestone Pharmaceuticals

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

landos-biopharma-logo

Landos Biopharma

Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.

lyndra-therapeutics-logo

Lyndra Therapeutics

Lyndra Therapeutics is a novel technology platform reinventing medicine for a healthier world.

alzheon-logo

Alzheon

Alzheon is a clinical-stage biotechnology company focused on brain health, memory and aging, developing a pipeline of innovative.

amcure-logo

amcure

amcure is a clinical-stage company develops peptide-based compounds for the treatment of highly metastatic forms of squamous cancer.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

avicanna-logo

Avicanna

Avicanna is a biotechnology company that focuses on the medical cannabis industry.

alvine-pharmaceuticals-logo

Alvine Pharmaceuticals

Alvine Pharmaceuticals is a biotechnology company developing therapeutics for autoimmune and inflammatory diseases.

aerpio-pharmaceuticals-logo

Aerpio Pharmaceuticals

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

first-wave-biopharma-logo

First Wave BioPharma

First Wave BioPharma aims to become a leader in developing non-systemic, recombinant protein therapies.

astrocyte-pharmaceuticals-logo

Astrocyte Pharmaceuticals

Astrocyte Pharmaceuticals is a drug development company dedicated to clinically proving the neuroprotective benefits.

enanta-pharmaceuticals-logo

Enanta Pharmaceuticals

Enanta Pharmaceuticals is an R&D companyย discovers, develops and promotesย of small molecule drugs in the areas of anti-infective.

eliem-therapeutics-logo

Eliem Therapeutics

Eliem Therapeutics is a clinical-stage biotechnology company developing treatments for nervous system disorders.

briacell-therapeutics-logo

BriaCell Therapeutics

BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.

iterion-therapeutics-logo

Iterion Therapeutics

Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics.

bioeclipse-therapeutics-logo

BioEclipse Therapeutics

BioEclipse Therapeutics is a clinical-stage oncology company that develops immuno-oncology therapeutics using its proprietary technology.

bind-therapeutics-logo

BIND Therapeutics

BIND Therapeutics isย a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.

bio-path-holdings-logo

Bio-Path Holdings

Bio-Path Holdings is a biotechnology company developing therapeutic products for the liposomal delivery of nucleic acids in cancer patients.

fusion-pharmaceuticals-logo

Fusion Pharmaceuticals

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals.

faraday-pharmaceuticals-logo

Faraday Pharmaceuticals

Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.

tremeau-pharmaceuticals-logo

Tremeau Pharmaceuticals

A privately funded clinical stage company based Massachusetts .

treadwell-therapeutics-logo

Treadwell Therapeutics

Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.

true-north-therapeutics-logo

True North Therapeutics

True North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.

third-harmonic-bio-logo

Third Harmonic Bio

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor.

juno-therapeutics-logo

Juno Therapeutics

Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.

janus-biotherapeutics-logo

Janus Biotherapeutics

Janus Biotherapeutics, an autoimmunity therapeutics company, develops orally available compounds for the treatment of autoimmune diseases.

korro-bio-logo

Korro Bio

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

k36-therapeutics-logo

K36 Therapeutics

K36 Therapeutics mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies.

not_available_image

Sorriso Pharmaceuticals

Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.

spring-bank-pharmaceuticals-logo

Spring Bank Pharmaceuticals

Spring Bank Pharmaceuticals is a discovery company developing a new class of pharmaceuticals called small molecule nucleic acid hybrids.

signpath-pharma-logo

Signpath Pharma

Signpath Pharma is a biotechnology company developing therapeutics using curcuminoids extracted from the root of the Curcuma longa plant.

satsuma-pharmaceuticals-logo

Satsuma Pharmaceuticals

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.

dcprime-logo

DCPrime

DCPrime is a clinical stage company which develops novel cancer immunotherapies based on its DCOne platform technology.

harpoon-therapeutics-logo

Harpoon Therapeutics

Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

imaginab-logo

ImaginAb

ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.

immvention-therapeutix-logo

IMMvention Therapeutix

IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for inflammatory diseases.

gamamabs-pharma-logo

GamaMabs Pharma

GamaMabs Pharma is a clinical-stage immuno-oncology company that developes optimized therapeutic antibodies for the treatment of cancer.

oncternal-therapeutics-logo

Oncternal Therapeutics

Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers.

osivax-logo

Osivax

Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies.

oncomed-pharmaceuticals-logo

OncoMed Pharmaceuticals

OncoMed Pharmaceuticals is a biotechnology company developing novel therapeutics for the treatment of cancer.

zz-biotech-logo

ZZ Biotech

A clinical stage company developing innovative biologic treatments for ischemic stroke.

cns-pharmaceutical-logo

CNS Pharmaceutical

CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.

civi-biopharma-logo

CiVi Biopharma

CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular.

cocrystal-pharma-logo

Cocrystal Pharma

Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics.

clover-biopharmaceuticals-logo

Clover Biopharmaceuticals

Clover Biopharmaceuticals is a clinical-stage biotechnology company focused on developing vaccines and biologic therapeutic.

cybrexa-therapeutics-logo

Cybrexa Therapeutics

Cybrexa Therapeutics is a cancer therapeutics company developing a new class of small molecule DNA repair.

calithera-biosciences-logo

Calithera Biosciences

Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.

checkmate-pharmaceuticals-logo

Checkmate Pharmaceuticals

Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.

cour-pharmaceuticals-development-logo

Cour Pharmaceuticals Development

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

prelude-logo

Prelude

Prelude delivers actionable tools to manage early stage breast cancer with the DCIS test that enables personalized treatment.

purec-logo

PuREC

PuREC is a developer of a culture technology intended to bring efficacy to the treatment process.

Current Employees Featured

henri-termeer_image

Henri Termeer
Henri Termeer Founder @ X4 Pharmaceuticals
Founder

renato-skerlj_image

Renato Skerlj
Renato Skerlj Founder @ X4 Pharmaceuticals
Founder

keith-flaherty_image

Keith Flaherty
Keith Flaherty Founder @ X4 Pharmaceuticals
Founder

adriana-badarau_image

Adriana Badarau
Adriana Badarau Senior Director, Discovery @ X4 Pharmaceuticals
Senior Director, Discovery
2021-01-01

derek-meisner_image

Derek Meisner
Derek Meisner General Counsel @ X4 Pharmaceuticals
General Counsel
2019-11-01

diego-cadavid_image

Diego Cadavid
Diego Cadavid Chief Medical Officer @ X4 Pharmaceuticals
Chief Medical Officer
2020-01-01

mary-dibiase_image

Mary DiBiase
Mary DiBiase Chief Operating Officer @ X4 Pharmaceuticals
Chief Operating Officer
2021-09-01

paula-ragan_image

Paula Ragan
Paula Ragan Founder, President and CEO @ X4 Pharmaceuticals
Founder, President and CEO
2014-07-01

barbara-grell_image

Barbara Grell
Barbara Grell Managing Director, Vienna Research Site @ X4 Pharmaceuticals
Managing Director, Vienna Research Site
2019-07-01

Founder


henri-termeer_image

Henri Termeer

keith-flaherty_image

Keith Flaherty

paula-ragan_image

Paula Ragan

renato-skerlj_image

Renato Skerlj

richard-peters_image

Richard Peters

Stock Details


Company's stock symbol is NASDAQ:XFOR

Acquisitions List

Date Company Article Price
2019-03-13 Arsanis Arsanis acquired by X4 Pharmaceuticals N/A

Investors List

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Equity - X4 Pharmaceuticals

bain-capital-life-sciences_image

Bain Capital Life Sciences

Bain Capital Life Sciences investment in Post-IPO Equity - X4 Pharmaceuticals

lumira-ventures_image

Lumira Ventures

Lumira Ventures investment in Post-IPO Equity - X4 Pharmaceuticals

orbimed-advisors_image

OrbiMed

OrbiMed investment in Post-IPO Equity - X4 Pharmaceuticals

axa-investment-managers_image

AXA Investment Managers

AXA Investment Managers investment in Post-IPO Equity - X4 Pharmaceuticals

acorn-bioventures_image

Acorn Bioventures

Acorn Bioventures investment in Post-IPO Equity - X4 Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Post-IPO Equity - X4 Pharmaceuticals

altium-capital_image

Altium Capital

Altium Capital investment in Post-IPO Equity - X4 Pharmaceuticals

driehaus-capital-management_image

Driehaus Capital Management

Driehaus Capital Management investment in Post-IPO Equity - X4 Pharmaceuticals

orbimed-advisors_image

OrbiMed

OrbiMed investment in Post-IPO Equity - X4 Pharmaceuticals

Official Site Inspections

http://www.x4pharma.com Semrush global rank: 4.86 M Semrush visits lastest month: 1.82 K

  • Host name: 209.103.196.104.bc.googleusercontent.com
  • IP address: 104.196.103.209
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "X4 Pharmaceuticals" on Search Engine